Education
About Us
Working with TipRanks
Follow Us
Cyclerion Therapeutics,Inc. (CYCN)
:CYCN
CYCN Stock Chart & Stats
$1.48
$0.00(0.00%)
At close: 4:00 PM EST
$1.48
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1.28 - $6.25
Previous CloseN/A
Volume28.13K
Average Volume (3M)721.52K
Market Cap
$6.75M
Enterprise ValueN/A
Total Cash (Recent Filing)$4.57M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.25
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.16
Shares Outstanding3,925,314
10 Day Avg. Volume49,139
30 Day Avg. Volume721,522
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.92
Price to Sales (P/S)4.05
P/FCF Ratio-1.87
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-33.4
Revenue Forecast (FY)$2.04M
Cyclerion Therapeutics News
CYCN FAQ
What was Cyclerion Therapeutics,Inc.’s price range in the past 12 months?
Cyclerion Therapeutics,Inc. lowest stock price was $1.28 and its highest was $6.25 in the past 12 months.
What is Cyclerion Therapeutics,Inc.’s market cap?
Cyclerion Therapeutics,Inc.’s market cap is $6.75M.
When is Cyclerion Therapeutics,Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cyclerion Therapeutics,Inc.’s earnings last quarter?
Cyclerion Therapeutics,Inc. released its earnings results on Feb 22, 2024. The company reported -$0.685 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.685.
Is Cyclerion Therapeutics,Inc. overvalued?
According to Wall Street analysts Cyclerion Therapeutics,Inc.’s price is currently Overvalued.
Does Cyclerion Therapeutics,Inc. pay dividends?
Cyclerion Therapeutics,Inc. does not currently pay dividends.
What is Cyclerion Therapeutics,Inc.’s EPS estimate?
Cyclerion Therapeutics,Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cyclerion Therapeutics,Inc. have?
Cyclerion Therapeutics,Inc. has 3,925,314 shares outstanding.
What happened to Cyclerion Therapeutics,Inc.’s price movement after its last earnings report?
Cyclerion Therapeutics,Inc. reported an EPS of -$0.685 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.42%.
Which hedge fund is a major shareholder of Cyclerion Therapeutics,Inc.?
Currently, no hedge funds are holding shares in CYCN
Company Description
Cyclerion Therapeutics,Inc.
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative treatments for serious diseases. The company operates within the biotechnology sector and primarily engages in the research and development of therapeutics aimed at central nervous system (CNS) disorders. Cyclerion leverages its expertise in soluble guanylate cyclase (sGC) stimulators to create novel therapeutics that address high unmet medical needs.
Technical Analysis
AIM ImmunoTech
―
Jaguar Animal Health
―
NLS Pharmaceutics
―
Alzamend Neuro
―
Calidi Biotherapeutics
―
Ownership Overview
15.03% Insiders
1.06% Mutual Funds
4.07% Other Institutional Investors
79.02% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---